DK375789A - Peptidderivater - Google Patents

Peptidderivater Download PDF

Info

Publication number
DK375789A
DK375789A DK375789A DK375789A DK375789A DK 375789 A DK375789 A DK 375789A DK 375789 A DK375789 A DK 375789A DK 375789 A DK375789 A DK 375789A DK 375789 A DK375789 A DK 375789A
Authority
DK
Denmark
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Application number
DK375789A
Other languages
Danish (da)
English (en)
Other versions
DK375789D0 (da
Inventor
John J Nestor
Brian H Vickery
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK375789D0 publication Critical patent/DK375789D0/da
Publication of DK375789A publication Critical patent/DK375789A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK375789A 1988-08-18 1989-07-31 Peptidderivater DK375789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23369088A 1988-08-18 1988-08-18

Publications (2)

Publication Number Publication Date
DK375789D0 DK375789D0 (da) 1989-07-31
DK375789A true DK375789A (da) 1990-02-19

Family

ID=22878305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK375789A DK375789A (da) 1988-08-18 1989-07-31 Peptidderivater

Country Status (11)

Country Link
EP (1) EP0363589A3 (de)
JP (1) JPH0273100A (de)
KR (1) KR900003205A (de)
AU (1) AU3926589A (de)
DK (1) DK375789A (de)
FI (1) FI893643A (de)
HU (1) HUT50487A (de)
IL (1) IL91166A0 (de)
NO (1) NO893088L (de)
PT (1) PT91384A (de)
ZA (1) ZA895838B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
DK0450480T3 (da) * 1990-04-06 1995-08-14 Univ Tulane Somatostatinaloger
ATE181240T1 (de) * 1991-02-08 1999-07-15 Biomeasure Inc Verwendung von somatostatinanalogen zur behandlung von melanomen
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
WO1995004752A1 (en) 1993-08-09 1995-02-16 Biomeasure, Inc. Therapeutic peptide derivatives
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
WO1998051330A1 (en) 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
ATE245998T1 (de) 1997-05-13 2003-08-15 Sod Conseils Rech Applic Somatostatin agoniste zur reduzierung von körpergewicht
DE69822810T2 (de) * 1997-05-13 2005-02-03 Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
ATE424414T1 (de) 2001-06-08 2009-03-15 Sod Conseils Rech Applic Chimere somatostatin-dopamin-analoga
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8709998B2 (en) 2003-04-22 2014-04-29 Ipsen Pharma S.A.S. Peptide vectors
CN102112145B (zh) 2008-06-12 2014-07-30 辛它可辛有限公司 神经内分泌病的抑制
EP2310029B1 (de) 2008-06-12 2019-04-03 Ipsen Bioinnovation Limited Fusionsproteine zur Verwendung bei der Behandlung von Krebs
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
ES2862125T3 (es) 2013-06-13 2021-10-07 Antisense Therapeutics Ltd Terapia combinada para acromegalia
CN108174843B (zh) * 2018-01-24 2018-11-13 广州市进德生物科技有限公司 一种胰高血糖素保护剂及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
FR2458539A1 (fr) * 1979-06-11 1981-01-02 Lilly Co Eli Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs

Also Published As

Publication number Publication date
NO893088D0 (no) 1989-07-31
DK375789D0 (da) 1989-07-31
FI893643A (fi) 1990-02-19
EP0363589A3 (de) 1990-08-16
JPH0273100A (ja) 1990-03-13
FI893643A0 (fi) 1989-08-01
HUT50487A (en) 1990-02-28
NO893088L (no) 1990-02-19
ZA895838B (en) 1991-03-27
PT91384A (pt) 1990-03-08
EP0363589A2 (de) 1990-04-18
AU3926589A (en) 1990-02-22
KR900003205A (ko) 1990-03-26
IL91166A0 (en) 1990-03-19

Similar Documents

Publication Publication Date Title
DK612689A (da) Peptidderivater
DK163689A (da) Peptidderivater
DK22588D0 (da) Peptidderivater
DK532787D0 (da) Peptidderivater
DK540289D0 (da) Protein
DK149889D0 (da) Soedemiddel
DE68925161D1 (de) Alkylavermectin-Derivate
DE68927948D1 (de) Trehalosderivate
DK375789D0 (da) Peptidderivater
DK19789D0 (da) Dehydrocholcalciferolderivater
DE68927657D1 (de) Butynylaminderivate
DK197989A (da) Peptidanaloger
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK301889D0 (da) Peptidderivater
DK395288D0 (da) Proteiner
DK84489A (da) Praeparater
DK177789A (da) Peptidderivater
FI91488B (fi) Seula
KR900700503A (ko) 펩티드
DK4390D0 (da) Peptidderivater
DK160389A (da) Aryldionderivater
DK657189A (da) Peptidderivater
ATA155589A (de) Mitomycinphosphat-derivate
DK679488A (da) Peptidderivater
DK171489D0 (da) Peptidderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment